Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$285K Buy
10,144
+875
+9% +$23.3K 0.05% 144
2025
Q4
$231K Sell
9,269
-140
-1% -$3.53K 0.04% 197
2025
Q3
$240K Sell
9,409
-1,818
-16% -$44.9K 0.05% 166
2025
Q2
$272K Sell
11,227
-14,175
-56% -$331K 0.05% 146
2025
Q1
$644K Buy
25,402
+2,426
+11% +$63.5K 0.13% 94
2024
Q4
$610K Buy
22,976
+4,191
+22% +$114K 0.11% 91
2024
Q3
$544K Sell
18,785
-1,882
-9% -$54.9K 0.12% 85
2024
Q2
$578K Buy
+20,667
New +$569K 0.13% 74

Other funds holding PFE

CacheTech Inc's PFE Position: Q1 2026 in Review

CacheTech Inc increased its Pfizer (PFE) stake by 9.4% in Q1 2026, buying an estimated $23.3K and bringing the position to 10,144 shares worth $285K. The position accounts for 0.05% of the portfolio, ranked #144.

CacheTech Inc first reported a position in PFE in Q2 2024 and has held it in 8 quarters since. The position peaked at $644K in Q1 2025. 2,935 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • CacheTech Inc held 10,144 shares of Pfizer worth $285K as of Q1 2026.
  • CacheTech Inc bought 875 Pfizer shares in Q1 2026, an estimated $23.3K.
  • Pfizer made up 0.05% of CacheTech Inc's portfolio in Q1 2026, its #144 holding.
  • CacheTech Inc first reported a position in Pfizer in Q2 2024 and has held it in 8 quarters since.
  • CacheTech Inc's Pfizer position peaked at $644K in Q1 2025.
  • 2,935 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on CacheTech Inc's 13F filing for Q1 2026, filed 12 May 2026.